Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial [Phase 3]
This document describes a Phase 3 multicenter randomized trial comparing methotrexate versus tocilizumab for Giant Cell Arteritis, currently…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Chewing Gum Test for the Diagnosis of Giant Cell Arteritis (Horton's Disease) - ChewingHort [NA]
A completed clinical trial evaluating a chewing gum diagnostic test for Giant Cell Arteritis (Horton disease).
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Giant Cell Arteritis and Anakinra Trial [Phase 3]
Phase 3 trial evaluating anakinra for Giant cell arteritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR [Phase 1]
Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of intravenous secukinumab in patients with Giant Cell Arteritis or …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) [Phase 3]
The document reports the completion of a Phase 3 trial evaluating secukinumab versus placebo, in combination with a glucocorticoid taper, fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of the T CD8 Immune Response in Horton's Disease
A completed clinical trial investigating the CD8+ T cell immune response in Giant Cell Arteritis (Horton’s disease).
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients
A completed trial comparing tocilizumab to methotrexate for corticosteroid-treated giant cell arteritis has been completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of secukinumab in adults with new-onset giant cell arteritis who are in clinical remissio…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell Arteritis
This clinical trial evaluated PET/CT imaging of the cephalic arteries for diagnosing giant cell arteritis. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
A clinical trial investigating orbital vascular inflammation in Giant Cell Arteritis and ischemic optic neuropathy (including NAION). The st…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis
The clinical trial assesses FDG PET/CT as a first-line diagnostic tool for Giant Cell Arteritis, with the study sponsored by Jewish General …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients [NA]
This clinical trial update describes a study in Giant Cell Arteritis evaluating halo sign vanishing time after steroid treatment; the trial …
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Cardiac Involvement in Patients With Giant Cell Arteritis
This clinical trial update summarizes completed findings on cardiac involvement in patients with Giant cell arteritis (GCA).
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis [Phase 2]
A Phase 2 study evaluating guselkumab for new-onset or relapsing giant cell arteritis has been terminated, with results posted on 2025-07-01…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]
This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients
Completed clinical trial assessing ultra-short glucocorticoid therapy in combination with tocilizumab for giant cell arteritis. The update c…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Giant Cell Arteritis - Optimization of Diagnostics
A completed clinical trial evaluating methods to optimize diagnostics for Giant Cell Arteritis.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of upadacitinib for giant cell arteritis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Validation of a Diagnostic Algorithm of Giant Cell Arteritis [NA]
This clinical trial update reports the validation of a diagnostic algorithm for giant cell arteritis. The study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis [Phase 2]
Clinical trial update indicating completion of a Phase 2 study evaluating ustekinumab for relapse of refractory giant cell arteritis.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)
An update on a completed study evaluating temporal artery biopsy histopathology after dynamic full-field optical coherence tomography (DOCTA…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis [Phase 2]
Phase 2 clinical trial evaluating methotrexate as remission maintenance therapy after remission-induction with tocilizumab and glucocorticoi…